Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Endocrinology

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/JOE-16-0513PMID 28428362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical Role

  2019cited by this paper
• Up-regulation of Peroxisome Proliferator-Activated Receptor in Perennial Allergic Rhinitis

  2016cited by this paper
• Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology

  2016cited by this paper
• Non-alcoholic fatty liver disease.

  2016cited by this paper
• Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.

  2016cited by this paper
• Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo

  2016cited by this paper
• Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.

  2016cited by this paper
• Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells

  2016cited by this paper
• Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

  2016cited by this paper
• Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients.

  2016cited by this paper
• Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance[S]

  2016cited by this paper
• Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome

  2016cited by this paper
• Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose

  2016cited by this paper
• Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.

  2016cited by this paper
• Mitochondrial Dynamics and Oxidative Stress Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity

  2016cited by this paper
• Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis

  2016cited by this paper
• Diagnosis of non-alcoholic fatty liver disease (NAFLD)

  2016cited by this paper
• Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference

  2016cited by this paper
• Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy

  2016cited by this paper
• Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

  2016cited by this paper
• Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice

  2016cited by this paper
• DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis.

  2016cited by this paper
• Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

  2016cited by this paper
• Nonalcoholic Fatty Liver Disease in Children: Role of the Gut Microbiota

  2016cited by this paper
• Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas

  2016cited by this paper
• Lipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD

  2016cited by this paper
• The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter

  2016cited by this paper
• Activation of OR1A1 suppresses PPAR-γ expression by inducing HES-1 in cultured hepatocytes.

  2015cited by this paper
• Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.

  2015cited by this paper
• Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice

  2015cited by this paper
• Hepatitis C Virus Attenuates Mitochondrial Lipid β-Oxidation by Downregulating Mitochondrial Trifunctional-Protein Expression

  2015cited by this paper
• Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome

  2015influential reference
• Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities.

  2015cited by this paper
• Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART).

  2015cited by this paper
• FGF21 and the late adaptive response to starvation in humans.

  2015cited by this paper
• Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency.

  2015cited by this paper
• Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients

  2015cited by this paper
• Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humans

  2015cited by this paper
• Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection

  2015cited by this paper
• Drug-induced fatty liver disease: An overview of pathogenesis and management.

  2015cited by this paper
• Prevalence of Nonalcoholic Fatty Liver Disease and Economy

  2015cited by this paper
• Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.

  2015cited by this paper
• Endocrine causes of nonalcoholic fatty liver disease.

  2015cited by this paper
• Differences and similarities in hepatic lipogenesis, gluconeogenesis and oxidative imbalance in mice fed diets rich in fructose or sucrose.

  2015cited by this paper
• 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.

  2015cited by this paper
• Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance*

  2015cited by this paper
• The role of lipin-1 in the pathogenesis of alcoholic fatty liver.

  2015cited by this paper
• Blocking High Fat Diet-induced Obesity, Insulin Resistance and Fatty Liver by Overexpression of Il-13 Gene in Mice

  2015cited by this paper
• Effects of acute exercise on lipid content and dietary lipid uptake in liver and skeletal muscle of lean and diabetic rats.

  2015cited by this paper
• Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein

  2015cited by this paper
• Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• microRNA‐379 couples glucocorticoid hormones to dysfunctional lipid homeostasis

  2014cited by this paper
• Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

  2014cited by this paper
• Mouse models of lipodystrophy and their significance in understanding fat regulation.

  2014cited by this paper
• FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

  2014cited by this paper
• Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

  2014cited by this paper
• Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation

  2014cited by this paper
• Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance

  2014cited by this paper
• Glucagon Stimulates Hepatic FGF21 Secretion through a PKA- and EPAC-Dependent Posttranscriptional Mechanism

  2014cited by this paper
• Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

  2014cited by this paper
• CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]

  2014cited by this paper
• Insulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle.

  2014cited by this paper
• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis

  2014cited by this paper
• Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study

  2014cited by this paper
• Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

  2014cited by this paper
• Liver Glycogen Reduces Food Intake and Attenuates Obesity in a High-Fat Diet–Fed Mouse Model

  2014cited by this paper
• Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development.

  2014cited by this paper
• Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

  2014cited by this paper
• Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease

  2014cited by this paper
• High-fat diet from perilla oil induces insulin resistance despite lower serum lipids and increases hepatic fatty acid oxidation in rats

  2014cited by this paper
• Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect

  2013cited by this paper
• Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity.

  2013cited by this paper
• Metformin trims fats to restore insulin sensitivity

  2013cited by this paper
• The liver diseases of lipodystrophy: the long-term effect of leptin treatment.

  2013cited by this paper
• HES1 Is a Master Regulator of Glucocorticoid Receptor–Dependent Gene Expression

  2013cited by this paper
• Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.

  2013cited by this paper
• Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass

  2013cited by this paper
• De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

  2013cited by this paper
• Glycogen shortage during fasting triggers liver–brain–adipose neurocircuitry to facilitate fat utilization

  2013cited by this paper
• Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol

  2013cited by this paper
• Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity

  2013cited by this paper
• Quantitative Proteomic and Functional Analysis of Liver Mitochondria from High Fat Diet (HFD) Diabetic Mice*

  2013cited by this paper
• Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding

  2013cited by this paper
• Keap1-Knockdown Decreases Fasting-Induced Fatty Liver via Altered Lipid Metabolism and Decreased Fatty Acid Mobilization from Adipose Tissue

  2013cited by this paper
• Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology

  2013cited by this paper
• A Role for Adipose Tissue De Novo Lipogenesis in Glucose Homeostasis During Catch-up Growth

  2013cited by this paper
• Non-alcoholic fatty liver disease in common endocrine disorders.

  2013cited by this paper
• Nonalcoholic Fatty Liver Disease and HIV Infection

  2012cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ

  2012cited by this paper
• Association between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

  2012cited by this paper
• A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis.

  2012cited by this paper
• In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats

  2012cited by this paper
• Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

  2012cited by this paper
• Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation

  2012cited by this paper
• A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease

  2012cited by this paper
• The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men

  2012cited by this paper
• Regulation of hepatic lipin‐1 by ethanol: Role of AMP‐activated protein kinase/sterol regulatory element‐binding protein 1 signaling in mice

  2012cited by this paper
• Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion

  2012cited by this paper
• Peroxisome proliferator‐activated receptor‐α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non‐alcoholic steatohepatitis

  2012cited by this paper

• Dietary supplemental L-Ornithine L-Aspartate reduced lipid deposition and alleviated mitochondrial oxidative stress and inflammatory responses in the liver of broiler chicken

  2026cites this paper
• Paternal Zearalenone Exposure Is Associated with Hepatic Dysfunction in F1 Offspring: Insights from Proteomic Analysis

  2026cites this paper
• NEDD4L knockdown reduced lipid accumulation in non-alcoholic fatty liver disease by promoting the activity of PI3K/AKT signaling pathway

  2025cites this paper
• Hepatoprotective, Antioxidant, and Anti-Hyperlipidemic Effects of Kefir Milk in High-Fat Diet-Induced Obesity: Insights from Gas Chromatography-Mass Spectrometry Profiling, Molecular Docking of Kefiran, and Liver Function Restoration

  2025cites this paper
• Cichoriin suppresses hepatic lipid accumulation and fibrosis in mice metabolic dysfunction associated steatohepatitis via the AMPK pathway.

  2025cites this paper
• Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female Mice

  2025cites this paper
• Axis-based propagation of nanoplastic toxicity: organ–organ crosstalk and systemic pathophysiological outcomes

  2025cites this paper
• The Role of Glycolysis in MASLD Development: Pathogenesis and Therapeutic Strategies.

  2025cites this paper
• Daily eating frequency, nighttime fasting duration, and the risk of non-alcoholic fatty liver disease: a cross-sectional study

  2025cites this paper
• Melatonin regulates accumulation of lipids in the liver via the IP3R on the mitochondria-associated membranes (MAMs).

  2025cites this paper
• Ethnic differences in adipose tissue dysfunction and insulin resistance: a scoping review.

  2025cites this paper
• Exploring the role of xanthine oxidase and aldehyde oxidase in metabolic dysfunction-associated steatotic liver disease (MASLD)

  2025cites this paper
• Enavogliflozin, an SGLT2 Inhibitor, Improves Nonalcoholic Steatohepatitis Induced by High-Fat, High-Cholesterol Diet

  2025cites this paper
• Short-chain per- and polyfluoroalkyl substances associate with elevated alanine aminotransferase: Cross-sectional analysis results from the STRIVE cohort.

  2025cites this paper
• Carbohydrate Deprivation Improves Glycolipid Metabolism and Activates AMPK/PGC1α Signaling Pathway in Mice

  2025cites this paper
• Hepatic lipidosis in psittacine birds—a review

  2025cites this paper
• Antiobesity medications in adult and pediatric obesity and metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Identification of key factors causing ketosis in dairy cows with low feed intake

  2025cites this paper
• Large‐Scale Production of Expandable Hepatoblast Organoids and Polarised Hepatocyte Organoids From hESCs Under 3D Static and Dynamic Suspension Conditions

  2025cites this paper
• Assessing clenbuterol’s modulation of metabolic and inflammatory pathways in Nile tilapia (Oreochromas niloticous) fed high fat diet

  2025cites this paper
• ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis

  2025cites this paper
• Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and Type 2 Diabetes via 5-HT2B receptor-dependent mechanisms.

  2025cites this paper
• Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides

  2024cites this paper
• Does Incretin Agonism Have Sustainable Efficacy?

  2024cites this paper
• Pea Albumin Alleviates Oleic Acid-Induced Lipid Accumulation in LO2 Cells Through Modulating Lipid Metabolism and Fatty Acid Oxidation Pathways

  2024cites this paper
• The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

  2024cites this paper
• Hormonal basis of seasonal metabolic changes in mammalian species.

  2024cites this paper
• ANGPTL8 deficiency attenuates lipopolysaccharide-induced liver injury by improving lipid metabolic dysregulation

  2024cites this paper
• Metabolic Effects of Ketogenic Diets: Exploring Whole-Body Metabolism in Connection with Adipose Tissue and Other Metabolic Organs

  2024cites this paper
• Heterocyclic Amines Disrupt Lipid Homeostasis in Cryopreserved Human Hepatocytes

  2024cites this paper
• Insulinsekretion und Insulinclearance in verschiedenen Diabetessubtypen

  2024cites this paper
• FGF21 mediating sex dependent response to dietary macronutrients.

  2024cites this paper
• Identification of genetic markers associated with hyperketonemia patterns in early lactation Holstein cows.

  2024cites this paper
• The Effect of Ovariectomy and Estradiol Substitution on the Metabolic Parameters and Transcriptomic Profile of Adipose Tissue in a Prediabetic Model

  2024cites this paper
• Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany.

  2024cites this paper
• Marine algae oils from Phaeodactylum tricornutum and Laminaria japonica alleviate obesity, insulin resistance, and gut microbiota dysbiosis in high-fat diet-fed mice

  2024cites this paper
• Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism.

  2024cites this paper
• Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea.

  2024cites this paper
• Elevation of hypothalamic ketone bodies induces a decrease in energy expenditures and an increase risk of metabolic disorder

  2024cites this paper
• Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats

  2024influential citation
• Characterization of palmitic acid toxicity induced insulin resistance in HepG2 cells.

  2024cites this paper
• Comparing the effects of developmental exposure to alpha lipoic acid (ALA) and perfluorooctanesulfonic acid (PFOS) in zebrafish (Danio rerio).

  2024cites this paper
• Multimodal mass spectrometry imaging identifies cell-type-specific metabolic and lipidomic variation in the mammalian liver.

  2024cites this paper
• Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis

  2024cites this paper
• Antipsychotic-induced alterations in lipid turnover.

  2023cites this paper
• Dimethylglycine Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease by Improving the Circulating Estrogen Level via Gut Staphylococcus.

  2023cites this paper
• Drynaria rhizome water extract alleviates high‑fat diet‑induced obesity in mice

  2023cites this paper
• Protein O‐GlcNAcylation: The sweet hub in liver metabolic flexibility from a (patho)physiological perspective

  2023cites this paper
• Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.

  2023cites this paper
• Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  2023cites this paper
• Hepatic melanomacrophage centers in the arctic cultured fish Cyclopterus lumpus are not indicative of its health state

  2023cites this paper
• Puberty as a DOHaD programming window: high-fat diet induces long-term hepatic dysfunction in male rats

  2023cites this paper
• Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?

  2023cites this paper
• Phenotypic and Metabolomic Characteristics of Mouse Models of Diet-Induced Hepatic Steatosis

  2023cites this paper
• Biallelic variants in LARS1 induce steatosis in developing zebrafish liver via enhanced autophagy

  2023cites this paper
• Construction of the Gal-NH2/mulberry leaf polysaccharides-lysozyme/luteolin nanoparticles and the amelioration effects on lipid accumulation.

  2023cites this paper
• Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD

  2023cites this paper
• Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects

  2023cites this paper
• Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis.

  2023cites this paper
• Effects of a high-fat low-carbohydrate diet under different energy conditions on glucose homeostasis and fatty liver development in rats and on gluconeogenesis in the isolated perfused liver.

  2023cites this paper
• Molecular Drug Simulation and Experimental Validation of the CD36 Receptor Competitively Binding to Long-Chain Fatty Acids by 7-Ketocholesteryl-9-carboxynonanoate

  2023cites this paper
• Visceral fat: A key mediator of NAFLD development and progression

  2023cites this paper
• The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg?

  2023cites this paper
• Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

  2023cites this paper
• The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD

  2023cites this paper
• Heart failure and obesity: The latest pandemic.

  2023cites this paper
• Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression

  2023cites this paper
• Semaphorin 4B is an ADAM17-cleaved adipokine that inhibits adipocyte differentiation and thermogenesis

  2023cites this paper
• Dietary supplementation of dimethyl itaconate protects against chronic heat stress-induced growth performance impairment and lipid metabolism disorder in broiler chickens.

  2023cites this paper
• Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes

  2023cites this paper
• Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis

  2023cites this paper
• Targeted Delivery of Butyrate Improves Glucose Homeostasis, Reduces Hepatic Lipid Accumulation and Inflammation in db/db Mice

  2023cites this paper
• Ectopic lipid metabolism in anterior pituitary dysfunction

  2023cites this paper
• Distinct responses from triglyceride and cholesterol metabolism in common carp (Cyprinus carpio) upon environmental cadmium exposure.

  2022cites this paper
• Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

  2022cites this paper
• Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway

  2022cites this paper
• Plasma lipidomics analysis reveals altered lipids signature in patients with osteonecrosis of the femoral head

  2022cites this paper
• Loss of RUBCN/rubicon in adipocytes mediates the upregulation of autophagy to promote the fasting response

  2022cites this paper
• Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice

  2022cites this paper
• Loquat (Eriobotrya japonica (Thunb) Lindl.): Evaluation of nutritional value, polyphenol composition, antidiabetic effect, and toxicity of leaf aqueous extract.

  2022cites this paper
• Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review

  2022cites this paper
• D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease

  2022cites this paper
• Determination of the Effects of Duodenal Infusion Soy Protein Hydrolysate on Hepatic Glucose and Lipid Metabolism in Pigs Through Multi-Omics Analysis

  2022cites this paper
• Monochromatic blue light not green light exposure is associated with continuous light-induced hepatic steatosis in high fat diet fed-mice via oxidative stress.

  2022cites this paper
• Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats

  2022cites this paper
• Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice

  2022cites this paper
• Alcoholic liver disease: a new insight into the pathogenesis of liver disease

  2022cites this paper
• Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport

  2022cites this paper
• Dependence of Seasonal Dynamics in Healthy People’s Circulating Lipids and Carbohydrates on Regional Climate: Meta-Analysis

  2022cites this paper
• A nexus of lipid and O-Glcnac metabolism in physiology and disease

  2022cites this paper
• DNA 6mA Demethylase ALKBH1 Orchestrates Fatty Acid Metabolism and Suppresses Diet-Induced Hepatic Steatosis

  2022cites this paper
• Multi-modal mass spectrometry imaging reveals single-cell metabolic states in mammalian liver

  2022cites this paper
• The ratio of 12α to non-12-hydroxylated bile acids reflects hepatic triacylglycerol accumulation in high-fat diet-fed C57BL/6J mice

  2022cites this paper
• Combined analysis of differentially expressed lncRNAs and miRNAs in liver tissues of high-fat fed rabbits by transcriptome sequencing

  2022cites this paper
• Emerging trends and hotspots in the links between the gut microbiota and MAFLD from 2002 to 2021: A bibliometric analysis

  2022cites this paper
• Semaphorin 4B is an ADAM17-cleaved inhibitor of adipocyte thermogenesis

  2022cites this paper
• Thymoquinone and quercetin protect against hepatic steatosis in association with SIRT1/AMPK stimulation and regulation of autophagy, perilipin-2, and cytosolic lipases

  2022cites this paper
• Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the hepatocyte nuclear factor 4α (Hnf4a) gene.

  2022cites this paper
• mass spectrometry imaging reveals single-cell metabolic states in mammalian

  2022cites this paper
• The Influence of Hyperglycemia on Liver Triglyceride Deposition in Partially Pancreatectomized Rats

  2022cites this paper